Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Wearable tech tracks how removing breathing tubes boosts patient health

NCT ID NCT07424196

Knowledge-focused Sponsor: Bin Zhang Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will use wearable devices to monitor the heart rate, breathing, and other vital signs of 60 patients before and after their tracheostomy tube is removed. The goal is to see if removing the tube leads to measurable improvements in health. Participants will wear the device at four key times: when they enter the hospital, before using a speaking valve, just before tube removal, and before discharge. The findings could help doctors decide when to safely remove tracheostomy tubes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could provide clear evidence that removing a tracheostomy tube improves patients' physiological health, encouraging earlier removal in clinical practice.
What could go wrong
This is a small, early observational study with only 60 participants, so results may not apply to all patients. It measures physiological parameters, not long-term outcomes, and the benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients underwent clinical and rehabilitation treatment both before and after decannulation.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * 18 years≤Age≤90 years, non-mechanically ventilated patients. * Tracheotomy completed, ≥48 hours since cannula placement (postoperative early edema has stabilized). * Patient or legal representative has provided informed consent. * Following our department's 2018 decannulation procedure, patients who successfully completed decannulation Exclusion Criteria: * Patients with abnormal skin conditions preventing continuous wearing of monitoring devices; * Interruption of physiological monitoring data; * Poor quality of physiological monitoring data; * Recent (≤48 hours) major neck/upper airway surgery requiring avoidance of upper airway airflow impact. * Severe consciousness disorder/delirium (RASS ≤ -3 or ≥ +2), extreme anxiety/inability to cooperate. * Total laryngectomy or laryngo-tracheal separation. * Age \<18 years, Age \> 90years. * Malignant tumor with an expected survival time ≤ 6 months. * Patients or legal representatives unable to obtain informed consent. * Known contraindications for tracheotomy decannulation. * Unable to comply with the use of wearable devices

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Physiological parameters are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.